SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Generalisability of Pharmacoeconomic Studies
16 references·1 citing·27 second hop
The Generalisability of Pharmacoeconomic Studies (1997)The Generalisability of Pharmacoeconomic …Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel …Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations for reporting…Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations for Reporting…Problems of using modelling in the economic evaluation of health care (1996)Problems of using modelling i…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Misleading meta-analysis (1995)Misleading meta-analysisEconomic Analysis of Health Care Technology: A Report on Principles (1995)Economic Analysis of Health C…What Price Depression? (1994)What Price Depression?Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and Potential (1993)Standardizing Methodologies f…Some guidelines on the use of cost effectiveness league tables. (1993)Some guidelines on the use of…Issues in the Cross-National Assessment of Health Technology (1992)Issues in the Cross-National …Economic Analysis in Randomized Control Trials (1992)Economic Analysis in Randomiz…Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature (1992)Cost-Effectiveness and Cost-B…Canadian Coordinating Office for Health Technology Assessment. (1992)Canadian Coordinating Office …Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Foundations of Cost-Effective…Assessment of transparency of cost estimates in economic evaluations of patient safety programmes (2009)Assessment of transparency of…Methods for the economic evaluation of health care programmes (1987)Quality of life and pharmacoeconomics in clinical trials (1996)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Cost-Effectiveness in Health and Medicine (1996)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Reference bias in reports of drug trials. (1987)A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts (1992)Publication bias: Its implications for clinical pharmacology (1992)Bias in meta-analysis detected by a simple, graphical test (1997)Measuring inconsistency in meta-analyses (2003)Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011)A Clinician's Guide to Cost-Effectiveness Analysis (1990)The estimation of a preference-based measure of health from the SF-36 (2002)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Criteria for evaluating evidence on public health interventions (2002)Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System (2002)Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report (2005)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Qaly league tables: Handle with care (1993)Problems With the Interpretation of Pharmacoeconomic Analyses (2000)Measurement of health state utilities for economic appraisal (1986)Markov Models in Medical Decision Making (1993)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Recommendations of the Panel on Cost-Effectiveness in Health and Medicine2,507 cited
  • 1977Foundations of Cost-Effectiveness Analysis for Health and Medical Practices2,136 cited
  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,828 cited
  • 1996Recommendations for Reporting Cost-effectiveness Analyses1,274 cited
  • 1996Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine1,037 cited
  • 1995Misleading meta-analysis508 cited
  • 1992Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature410 cited
  • 1992Canadian Coordinating Office for Health Technology Assessment.293 cited
  • 1993Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and Potential230 cited
  • 1994What Price Depression?222 cited
  • 1995Economic Analysis of Health Care Technology: A Report on Principles220 cited
  • 1993Some guidelines on the use of cost effectiveness league tables.219 cited
  • 1992Economic Analysis in Randomized Control Trials188 cited
  • 1996Problems of using modelling in the economic evaluation of health care

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

163 cited
  • 1992Issues in the Cross-National Assessment of Health Technology160 cited
  • Cited by

    • 2009Assessment of transparency of cost estimates in economic evaluations of patient safety programmes51 cited